Anti-integrin portfolio

Allegro has announced the expansion of the company’s anti-integrin portfolio

Anti-integrin portfolio
Colin Kerr
Colin Kerr
Published: Saturday, June 1, 2019
Allegro Ophthalmics has announced the expansion of the company’s anti-integrin portfolio with ALG-1007, a topical treatment in development for potential use in patients with dry eye disease (DED). ALG-1007 bolsters Allegro’s existing anti-integrin portfolio, which includes risuteganib (Luminate®), currently being developed for diabetic macular oedema (DME) and intermediate dry age-related macular degeneration (AMD). Allegro has also announced that Richard L. Lindstrom MD, Edward J. Holland MD and Eric D. Donnenfeld MD, have joined the company’s newly formed Cornea Scientific Advisory Board (Cornea SAB) to provide strategy and direction on Allegro’s clinical development pipeline in the areas of corneal disease and dry eye. Dr Lindstrom will serve as Chairperson of the Cornea SAB. https://www.allegroeye.com
Latest Articles
Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

Read more...

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Read more...

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Read more...

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Read more...

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Read more...

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.

Read more...

Matching Premium IOLs to Visual Lifestyles

From monofocal to full-range solutions, each practice needs comprehensive understanding.

Read more...

Going Dutch on Acanthamoeba Keratitis

A world-first trial suggests a new medication could beat the disease.

Read more...

Avoiding Intracorneal Ring Segment Complications

Femtosecond lasers are helping improve refractive results with fewer problems.

Read more...

Fine-Tuning IOLs After Surgery

Lens power adjustment technology is developing quickly.

Read more...